~~<i id='E49CE57327'><strike id='E49CE57327'><tt id='E49CE57327'><pre id='E49CE57327'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

explore

author：focus 2025-09-05 11:27:46 - browse：1

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Can U.S. cancer drug shortages be fixed?

entertainment

hotspot

knowledge

Wikipedia

focus

explore

CommitteechairmanRep.JasonSmith(R-Mo.)speakswithrankingmemberRep.RichardNeal(D-Mass.).DrewAngerer/Ge

WSS

How dance can help nurses traumatized by Covid

Vivek Ramaswamy made waves in the debate, much as in biotech

Startup Neumora takes a novel depression drug to Phase 3

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

How Medicaid coverage policies for immigrants impact new moms

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

leisure time

explore

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

FDA greenlights medical device to combat bladder issues

23andMe had bad news about my health. I wish a person had delivered it

Wegovy improves function in certain heart failure patients

Medicare proposal to cover medical devices draws a mixed reaction

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Jerome Adams on the need for new antivirals for Covid

Roche's accidental data boosts hopes for anti

In age of alternative facts, a scholarly course on calling out crap

Why hospitals are withdrawing from US News rankings

hotspot

FDA greenlights medical device to combat bladder issues

Vivek Ramaswamy made waves in the debate, much as in biotech

Listen: Vivek Ramaswamy's star turn & leaky drug data

People can get long Covid without testing positive for virus: Study

Listen: Vivek Ramaswamy's star turn & leaky drug data

Wegovy improves function in certain heart failure patients

knowledge

Wikipedia

focus

explore